[spacer image]
BD
[spacer image]
[spacer image]

Quick Facts
[spacer image] By shortening diagnosis time, the BD MGIT™ (Mycobacteria Growth Indicator Tube) system can help stop tuberculosis. More Information » [spacer image]
[spacer image]

News & Events
Print
[spacer image]
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

Contact: Patricia A.  Spinella
Investor Relations
(201) 847-5453
Email: patricia_spinella@bd.com

Colleen T.  White
Corporate Communications
(201) 847-5369
Email: colleen_white@bd.com

Franklin Lakes, NJ (June 29, 2009) --

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2009 earnings conference call on Thursday, July 30, 2009, at 10:00 a.m. (ET).  BD will issue a press release detailing the quarter’s earnings earlier that morning.

The webcast of the conference call, along with related slides, will be accessible through BD’s website at www.bd.com/investors and will be available for replay through Thursday, August 6, 2009.   

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents.  The Company is dedicated to improving people’s health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines.  BD’s capabilities are instrumental in combating many of the world’s most pressing diseases.  Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 counties throughout the world.  The company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.  For more information, please visit www.bd.com.

[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]